A novel and innovative approach to treating metastasized cancer, starting with the very lethal grade 4 pancreatic cancer. Earlier this year, scientists from Columbia University in New York demonstrated that the growth rate of pancreatic ...
Read MoreSAN ?WANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) -- Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU. As a bioequivalent version of Victoza ® pre-filled pen, ...
Read MoreTAIPEI, Taiwan, June 12, 2024 (GLOBE NEWSWIRE) -- OBI Pharma, a clinical-stage oncology company (4174.TWO), today announced the initiation of a Phase 1/2 clinical trial of OBI-992, an antibody-drug conjugate (ADC) targeting TROP2 (Trophoblast ...
Read MoreSAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy ...
Read MoreNEW YORK , Nov. 22, 2015 /PRNewswire-iReach/ -- An international study, entitled "The Global Burden of Disease," reported that 2.3 billion people suffered from five or more health problems in 2013. That is almost one-third of the world's ...
Read MoreSubscribe to our Free Newsletters!